title: Screening for gene mutations: will identification of NT5C2 mutations help predict the chance of relapse in acute lymphoblastic leukemia?
authors.forename: Julia A
authors.initials: JA
authors.lastname: Meyer
authors.forename: William L
authors.initials: WL
authors.lastname: Carroll
authors.forename: Teena
authors.initials: T
authors.lastname: Bhatla
mesh_terms: D015720:5'-Nucleotidase / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D000880:Anthraquinones / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000235:genetics; D019008:Drug Resistance, Neoplasm; D006801:Humans; D009154:Mutation; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D012008:Recurrence; D013866:Thioguanine / Q000627:therapeutic use
chemical_list: D000880:Anthraquinones; D014408:Biomarkers, Tumor; C408124:anthraquinone-2,6-disulfonate; D015720:5'-Nucleotidase; C508048:NT5C2 protein, human; D013866:Thioguanine